title: Completion lymphadenectomy may not increase in-transit disease in malignant melanoma.
authors.forename: Robin
authors.initials: R
authors.lastname: Russell-Jones
authors.forename: Ciaran
authors.initials: C
authors.lastname: Healy
authors.forename: Ann-Marie
authors.initials: AM
authors.lastname: Powell
authors.forename: Katharine
authors.initials: K
authors.lastname: Acland
authors.forename: Michael
authors.initials: M
authors.lastname: O'Doherty
authors.forename: Eduardo
authors.initials: E
authors.lastname: Calonje
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D015331:Cohort Studies; D000075202:Contraindications; D018572:Disease-Free Survival; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008197:Lymph Node Excision / Q000379:methods; D008207:Lymphatic Metastasis; D008545:Melanoma / Q000556:secondary* / Q000601:surgery*; D009364:Neoplasm Recurrence, Local; D021701:Sentinel Lymph Node Biopsy / Q000379:methods
chemical_list: D000970:Antineoplastic Agents; D007372:Interferons